Table 1.
Factor | Strata | n | % |
---|---|---|---|
Total | 167 | 100 | |
Sex | Male | 84 | 50 |
Female | 83 | 50 | |
Histological subtype | Undifferentiated pleomorphic sarcoma | 55 | 33 |
Leiomyosarcoma | 30 | 18 | |
Synovial sarcoma | 20 | 12 | |
Liposarcoma | 35 | 21 | |
Angiosarcoma | 5 | 3 | |
MPNST | 9 | 5 | |
Other | 13 | 8 | |
Grading | Intermediate (G2) | 84 | 50 |
High (G3) | 83 | 50 | |
Location | Extremities | 58 | 35 |
Non-Extremities | 109 | 65 | |
Size | 50–80 mm | 56 | 33 |
≥80 mm | 93 | 56 | |
Missing | 18 | 11 | |
Surgical margins | R0 | 44 | 26 |
R1 | 96 | 58 | |
R2 or no resection | 27 | 16 | |
AJCC stage | Stage II | 31 | 18 |
Stage III | 118 | 71 | |
Missing | 18 | 11 | |
Tumor response | Complete/partial response | 24 | 14 |
Stable disease | 78 | 47 | |
Progressive disease | 24 | 14 | |
Missing | 41 | 25 | |
TOP2A expression | Low (0–9%) | 88 | 53 |
High (10–100%) | 79 | 47 | |
SIRT1 expression | Low (0–9%) | 67 | 40 |
High (10–100%) | 100 | 60 |